LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the EVO/EVO+ Visian implantable Collamer lens for the correction of myopia and myopia with ...

In March 2022, the U.S. Food and Drug Administration (FDA) granted approval of the EVO/EVO+ Visian Implantable Collamer Lens (EVO) for the correction of myopia and myopia with astigmatism. Myopia is ...

Please provide your email address to receive an email when new articles are posted on . Intraocular lens surgery was once seen as a last resort for patients interested in spectacle independence, but ...

Implantable Lenses (Phakic IOLs) FDA 3-year follow up study on Visian ICL Is the ICL better than LVC? (PDF) This sounded a lot better than Lasik to me; the concept of adding a component to my eye, ...

Staar Surgical Co. said sales of its implantable contact lens rose about 52 percent in the third quarter, primarily due to greater overseas demand. The Monrovia ophthalmic products maker is scheduled ...

“EVO ICL is the next logical step in refractive innovation. While adoption of any new technology takes time, EVO ICL’s adoption rate has been steadily rising since launch – achieving market leadership ...

Staar Surgical Co. on Tuesday said that its Visian implantable lens for people with astigmatism has been approved for sale in Japan, a potentially huge market for the Morovia company. The Visian Toric ...